FR2871378B1 - Nouveau medicament a base de flavanois et de leurs derives et son utilisation pour obtenir un medicament destine a la prevention de la restenose et de la maladie atheromateuse chez les patients coronariens - Google Patents

Nouveau medicament a base de flavanois et de leurs derives et son utilisation pour obtenir un medicament destine a la prevention de la restenose et de la maladie atheromateuse chez les patients coronariens

Info

Publication number
FR2871378B1
FR2871378B1 FR0451279A FR0451279A FR2871378B1 FR 2871378 B1 FR2871378 B1 FR 2871378B1 FR 0451279 A FR0451279 A FR 0451279A FR 0451279 A FR0451279 A FR 0451279A FR 2871378 B1 FR2871378 B1 FR 2871378B1
Authority
FR
France
Prior art keywords
flavanois
restenosis
medicament
prevention
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0451279A
Other languages
English (en)
Other versions
FR2871378A1 (fr
Inventor
Ramaroson Andriantsitohaina
Gerald Roul
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
FR DE DISTILLERIES SOC
Societe dExploitation de Produits pour les Industries Chimiques SEPPIC SA
Original Assignee
FR DE DISTILLERIES SOC
Societe dExploitation de Produits pour les Industries Chimiques SEPPIC SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by FR DE DISTILLERIES SOC, Societe dExploitation de Produits pour les Industries Chimiques SEPPIC SA filed Critical FR DE DISTILLERIES SOC
Priority to FR0451279A priority Critical patent/FR2871378B1/fr
Priority to EP05777170A priority patent/EP1765372A1/fr
Priority to US11/629,524 priority patent/US20080139486A1/en
Priority to PCT/FR2005/001505 priority patent/WO2006003331A1/fr
Publication of FR2871378A1 publication Critical patent/FR2871378A1/fr
Application granted granted Critical
Publication of FR2871378B1 publication Critical patent/FR2871378B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR0451279A 2004-06-15 2004-06-15 Nouveau medicament a base de flavanois et de leurs derives et son utilisation pour obtenir un medicament destine a la prevention de la restenose et de la maladie atheromateuse chez les patients coronariens Expired - Fee Related FR2871378B1 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FR0451279A FR2871378B1 (fr) 2004-06-15 2004-06-15 Nouveau medicament a base de flavanois et de leurs derives et son utilisation pour obtenir un medicament destine a la prevention de la restenose et de la maladie atheromateuse chez les patients coronariens
EP05777170A EP1765372A1 (fr) 2004-06-15 2005-06-15 Medicament a base de flavanols pour le traitement et/ou la prevention de la restenose endoprothetique et la maladie atheromateuse chez des patients coronariens
US11/629,524 US20080139486A1 (en) 2004-06-15 2005-06-15 Flavonol-Based Medicine For Treating And/Or Preventing Endoprosthetic Restenosis And atheromatous Disease In Coronary Patients
PCT/FR2005/001505 WO2006003331A1 (fr) 2004-06-15 2005-06-15 Medicament a base de flavanols pour le traitement et/ou la prevention de la restenose endoprothetique et la maladie atheromateuse chez des jpatients coronariens

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0451279A FR2871378B1 (fr) 2004-06-15 2004-06-15 Nouveau medicament a base de flavanois et de leurs derives et son utilisation pour obtenir un medicament destine a la prevention de la restenose et de la maladie atheromateuse chez les patients coronariens

Publications (2)

Publication Number Publication Date
FR2871378A1 FR2871378A1 (fr) 2005-12-16
FR2871378B1 true FR2871378B1 (fr) 2007-03-30

Family

ID=34953821

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0451279A Expired - Fee Related FR2871378B1 (fr) 2004-06-15 2004-06-15 Nouveau medicament a base de flavanois et de leurs derives et son utilisation pour obtenir un medicament destine a la prevention de la restenose et de la maladie atheromateuse chez les patients coronariens

Country Status (4)

Country Link
US (1) US20080139486A1 (fr)
EP (1) EP1765372A1 (fr)
FR (1) FR2871378B1 (fr)
WO (1) WO2006003331A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0819958D0 (en) * 2008-10-31 2008-12-10 Provexis Natural Products Ltd Therapeutic compositions
GB0819959D0 (en) 2008-10-31 2008-12-10 Provexis Natural Products Ltd Fruit extracts
US8052423B2 (en) 2009-08-24 2011-11-08 King Abdulaziz University Tunneling method for dental block grafting
WO2013163057A1 (fr) 2012-04-23 2013-10-31 University Of Oslo Utilisation d'extrait de tomate comme agent antihypertenseur et procédé de fabrication d'extrait de tomate exempt de sucre soluble dans l'eau
GB201223365D0 (en) 2012-12-24 2013-02-06 Provexis Natural Products Ltd Compositions
AU2017353349B2 (en) 2016-11-02 2022-04-21 Provexis Natural Products Limited Water soluble tomato extract protects against adverse effects of air pollution
CN113827583B (zh) * 2021-11-16 2023-02-17 华中科技大学同济医学院附属协和医院 杨梅醇的用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6642277B1 (en) * 1996-09-20 2003-11-04 The Howard Foundation Food supplements containing polyphenols
US6238673B1 (en) * 1996-09-20 2001-05-29 The Howard Foundation Method of producing high flavonol content polyphenol compositions
KR100379323B1 (ko) * 2000-02-29 2003-04-08 삼아약품 주식회사 카테킨을 포함하는 관상동맥 재협착 예방 및 치료용 약학조성물

Also Published As

Publication number Publication date
WO2006003331A1 (fr) 2006-01-12
US20080139486A1 (en) 2008-06-12
FR2871378A1 (fr) 2005-12-16
EP1765372A1 (fr) 2007-03-28

Similar Documents

Publication Publication Date Title
EP1651195A4 (fr) Procedes pharmaceutiques, posologies et formes posologiques pour le traitement de la maladie d'alzheimer
EP1945628A4 (fr) Nouveaux derives de pyrimidine et leur utilisation en therapie et pour la production d'un medicament pour la prevention et/ou le traitement de la maladie d'alzheimer
CY2013004I1 (el) Προϊοντα συζευξης auristatin και χρηση αυτων για θεραπεια καρκινου, αυτοανοσης ασθενειας ή μολυσματωδους ασθενειας
NO2014032I2 (no) Kombinasjon av rilpivirin eller et farmasøytisk akseptabelt salt av rilpivirin, medregnet hydrokloridsaltet av rilpivirin, emtricitabin og tenofovir, spesielt tenofovir disoproksil eller tenofovirdisoproksilfumarat.
HUP0402594A3 (en) Drug delivery systems for the prevention and treatment of vascular diseases comprising rapamycin and derivatives thereof
AU2003234231A1 (en) New polyarylates for drug delivery and tissue engineering
FR2867778B1 (fr) Utilisation de derives d'indazolecarboxamides pour la preparation d'un medicament destine au traitement et a la prevention du paludisme
HK1106136A1 (en) Use of substituted quinoline derivatives for the treatment of drug resistant mycobacterial diseases
FR2871378B1 (fr) Nouveau medicament a base de flavanois et de leurs derives et son utilisation pour obtenir un medicament destine a la prevention de la restenose et de la maladie atheromateuse chez les patients coronariens
IL179473A0 (en) Pharmaceutical products for treating neoplastic disease and inflammation
BRPI0610780A2 (pt) formulação farmacéutica em tablete desintegrante, e, métodos para tratar um paciente em necessidade de tratamento com olanzapina, e para produzir a formulação farmacêutica em tablete
WO2006060325A3 (fr) Formulations enrobees d'administration de medicaments
EP1500401A4 (fr) Medicaments de traitement de maladies vasculaires
DE602004027730D1 (de) Medizinisches knochenprothesematerial und verfahren zu seiner herstellung
AU2003291536A8 (en) Method for the diagnosis and treatment of vascular disease
PL1680112T3 (pl) N-(5-adamantan-1-ylometoksypentylo)deoksynojirimycyna lub dopuszczalna farmaceutycznie sól stosowane w leczeniu oporności na insulinę
PL1643999T3 (pl) Pirydoksamina do zastosowania w leczeniu nefropatii cukrzycowej w cukrzycy typu II
WO2012073245A8 (fr) Conjugués d'un phospholipide et d'un médicament destinés au traitement d'une affection inflammatoire de l'intestin
FR2846852B1 (fr) Support appetent pour medicament destine a un animal
FI20055026A (fi) Järjestelmä ihmisen fysiologisen tilan hallintaan ja tietokoneohjelmistotuote
JP2004521140A5 (fr)
HK1075654A1 (en) Hyperforin derivatives, the use thereof and formulations containing them
JP2005505605A5 (fr)
NO20043633L (no) Oral doseringsform for kontrollert medikamentfrigivning
FR2857222B1 (fr) Microbicide antiseptique, et cosmetique, medicament et aliment incorporant ledit microbicide antiseptique

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20111118